Mavoglurant
- Generic Name
- Mavoglurant
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H23NO3
- CAS Number
- 543906-09-8
- Unique Ingredient Identifier
- GT0I9SV4F6
- Background
Mavoglurant has been used in trials studying the treatment of Patient Diagnosed With OCD and and Resistant to SSRI Treatment (Failed SSRI Over 12 Weeks at Appropriate Doses).
- Associated Conditions
- -
- Associated Therapies
- -
Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Yale University
- Target Recruit Count
- 63
- Registration Number
- NCT06136195
- Locations
- 🇺🇸
Connecticut Mental Health Center (SAC and SATU), New Haven, Connecticut, United States
🇺🇸Yale New Haven Hospital, New Haven, Connecticut, United States
Mavoglurant in Alcohol Drinking
- First Posted Date
- 2017-10-31
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Yale University
- Target Recruit Count
- 34
- Registration Number
- NCT03327792
- Locations
- 🇺🇸
CMHC, Substance Abuse Center, New Haven, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath